Timeline
Inmazeb
Regeneron's triple Ebola monoclonal antibody cocktail; FDA-approved 2020 for Zaire only; not effective against Bundibugyo.
6 of 6 entries (6 events, 0 interactions)
Filters
#712 Jun
Mentioned in: First Ebola treatment trial goes live
Pandemics and Biosecurity#61 Jun
Mentioned in: $112m for vaccines, none for the wards
Pandemics and Biosecurity#51 Jun
Licensed Ebola therapeutic targeting only the Zaire species
Pandemics and Biosecurity: Mentioned in: Only Ebola treatment still cannot dose#529 May
Mentioned in: Ebola passes 1,000 cases in DRC
Pandemics and Biosecurity#317 May
Mentioned in: USAID outbreak unit gone by PHEIC
Pandemics and Biosecurity#317 May